Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines

The drug-induced proliferation (DIP) rate is a metric of in vitro drug response that avoids inherent biases in commonly used metrics such as 72h viability. However, DIP rate measurements rely on direct cell counting over time, a laborious task that is subject to numerous challenges, including the need to fluorescently label cells and automatically segment nuclei. Moreover, it is incredibly difficult to directly count cells and accurately measure DIP rates for cell populations in suspension. As an alternative, we use real-time luminescence measurements derived from the cellular activity of NAD(P)H oxidoreductase to efficiently estimate drug response in both adherent and suspension cell populations to a panel of known anticancer agents. For the adherent cell lines, we collect both luminescence reads and direct cell counts over time simultaneously to assess their congruency. Our results demonstrate that the proposed approach significantly speeds up data collection, avoids the need for cellular labels and image segmentation, and opens the door to significant advances in high-throughput screening of anticancer drugs.

[1]  B. Bornhauser,et al.  Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia , 2019, Front. Cell Dev. Biol..

[2]  S. Auerbach,et al.  Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage , 2017, PloS one.

[3]  Daniel F Gilbert,et al.  Cell Viability Assays , 2016, Methods in Molecular Biology.

[4]  P. Sorger,et al.  Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.

[5]  Weibo Cai,et al.  NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence. , 2016, Bioconjugate chemistry.

[6]  Carlos F. Lopez,et al.  An unbiased metric of antiproliferative drug effect in vitro , 2016, Nature Methods.

[7]  Richard J. McMurtrey,et al.  Analytic Models of Oxygen and Nutrient Diffusion, Metabolism Dynamics, and Architecture Optimization in Three-Dimensional Tissue Constructs with Applications and Insights in Cerebral Organoids , 2015, Tissue engineering. Part C, Methods.

[8]  K. Wennerberg,et al.  Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor Screening , 2015, Assay and drug development technologies.

[9]  V. Quaranta,et al.  Quantifying heterogeneity and dynamics of clonal fitness in response to perturbation , 2015, Journal of cellular physiology.

[10]  Mohammad Fallahi-Sichani,et al.  Metrics other than potency reveal systematic variation in responses to cancer drugs. , 2013, Nature chemical biology.

[11]  J. Keith Joung,et al.  piggyBac transposase tools for genome engineering , 2013, Proceedings of the National Academy of Sciences.

[12]  Brock F. Binkowski,et al.  Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.

[13]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[14]  N. Carragher,et al.  Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery , 2011, Pharmaceutics.

[15]  A. Bradley,et al.  A hyperactive piggyBac transposase for mammalian applications , 2011, Proceedings of the National Academy of Sciences.

[16]  H. Atmaca,et al.  Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (−/− gossypol) , 2010, Toxicology mechanisms and methods.

[17]  David Heber,et al.  Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols , 2010, PloS one.

[18]  W. Mutschler,et al.  Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. , 2008, Tissue engineering. Part A.

[19]  Jos Malda,et al.  The roles of hypoxia in the in vitro engineering of tissues. , 2007, Tissue engineering.

[20]  E. Butcher.  Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.

[21]  Robert E Guldberg,et al.  Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. , 2003, Tissue engineering.

[22]  Jurek Dobrucki,et al.  Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. , 2002, Cytometry.

[23]  T. Bezabeh,et al.  Detection of drug-induced apoptosis and necrosis in human cervical carcinoma cells using 1H NMR spectroscopy , 2001, Cell Death and Differentiation.

[24]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[25]  J. G. Cory,et al.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. , 1991, Cancer communications.

[26]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[27]  Patries M Herst,et al.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. , 2005, Biotechnology annual review.

[28]  F. P. Altman.  Tetrazolium salts and formazans. , 1976, Progress in histochemistry and cytochemistry.